Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02479906 · ClinicalTrials.gov registry record · NA
A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD)
A NA study, sponsored by Brainsway.
- Terminated
- Registry status
- NA
- Development phase
- 203
- Enrollment target
NCT02479906 is a NA study that was terminated before completion, run by Brainsway. The registered enrollment target is 203 participants.
The verdict
NCT02479906, a NA study, was terminated before completion, sponsored by Brainsway.
- TERMINATED
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
Study Summary
The purpose of the present study is to evaluate the safety and efficacy of Brainsway Deep TMS (DTMS) for the treatment of PTSD.
Interventions
- DEVICE Sham Treatment
- DEVICE Deep TMS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2016-11-17 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02479906
The ClinicalTrials.gov registry entry for NCT02479906 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brainsway, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Treatment is the first listed.
NCT02479906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02479906 about?
NCT02479906 is a clinical study titled "A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD)". The purpose of the present study is to evaluate the safety and efficacy of Brainsway Deep TMS (DTMS) for the treatment of PTSD.
What is the current status of trial NCT02479906?
This trial is currently terminated. It is a NA study. The enrollment target is 203 participants. The study started on 2016-11-17. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT02479906?
The interventions under investigation include: Sham Treatment (DEVICE), Deep TMS System (DEVICE).
Who is sponsoring clinical trial NCT02479906?
This trial is sponsored by Brainsway, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.